NRXBF Keeps Proving its Treatment is Superior

NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to ...
TipRanks on MSN

IBIO, RLMD, SEE, OLLI, Invivyd trending with analysts

Analysts are intrested in these 5 stocks: ( ($IBIO) ), ( ($RLMD) ), ( ($SEE) ), ( ($OLLI) ) and ( ($IVVD) ). Here is a breakdown of their recent ...
Medindia

Beyond Obesity: Why GLP-1 Medicines are Redefining the 2026 Pharmaceutical Landscape

GLP-1 medicines have been utilised for the treatment of diabetes; however, they are now emerging as important topics for the treatment of obesity ...
Precision Medicine Online

Gene Therapies in 2025: Bespoke CRISPR Drugs to New FDA Pathways Energize Rare Disease Treatment

Now, Musunuru and colleagues are preparing a master clinical protocol to study a CRISPR therapy that's mostly the same as the one they used to treat baby KJ, except they plan to swap out the gene ...